Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sprinklr (CXM) Liabilities and Shareholders Equity (2021 - 2026)

Sprinklr's Liabilities and Shareholders Equity history spans 6 years, with the latest figure at $1.2 billion for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity rose 1.76% year-over-year to $1.2 billion; the TTM value through Jan 2026 reached $4.5 billion, up 6.39%, while the annual FY2026 figure was $1.2 billion, 1.76% up from the prior year.
  • Liabilities and Shareholders Equity reached $1.2 billion in Q1 2026 per CXM's latest filing, up from $1.1 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.2 billion in Q1 2024 to a low of $897.0 million in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2025.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 54.11% in 2022, then dropped 10.79% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $897.0 million in 2022, then rose by 21.26% to $1.1 billion in 2023, then dropped by 10.79% to $970.3 million in 2024, then rose by 8.61% to $1.1 billion in 2025, then grew by 14.34% to $1.2 billion in 2026.
  • Per Business Quant, the three most recent readings for CXM's Liabilities and Shareholders Equity are $1.2 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025).